CVM CEL-SCI Corp.
-
CEL-SCI Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
CEL-SCI (CVM) reported a loss of $0.47 per share on revenue of $0.00 million for the . .
CEL-SCI Corp is a biotechnology company. It is engaged in the research & development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body' natural defense system.
Reported Earnings
($0.47)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—